Procaps Group SA
PROC
$1.49
Closing
▼-6.01%
1D
▼-63.51%
YTD
PROC
BBG00ZVY4GT2
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$167.54M
Analysts' Rating
BUY
Price Target (Mean)
4.75
Total Analysts
1
P/E
2.85
Operating Margin
11.13%
Beta
0.06
Revenue Growth
7.25%
52 week high
$4.95
52 week low
$0.50
Div. Yield
%
EPS Growth
0.00
Company Profile
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
